These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. CD4+ CD25+ regulatory T cells approach the clinic. Edinger M Cytotherapy; 2008; 10(7):655-6. PubMed ID: 18985471 [No Abstract] [Full Text] [Related]
34. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report. Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927 [TBL] [Abstract][Full Text] [Related]
36. c-ANCA as a marker of Wegener's disease. Bosch X; Urbano-Márquez A Lancet; 1996 Jan; 347(8994):117; author reply 118. PubMed ID: 8538309 [No Abstract] [Full Text] [Related]
37. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules. Shen X; Niu C; König R Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721 [TBL] [Abstract][Full Text] [Related]
38. c-ANCA as a marker of Wegener's disease. Niles JL; McCluskey RT Lancet; 1996 Jan; 347(8994):116-7; author reply 118. PubMed ID: 8538308 [No Abstract] [Full Text] [Related]
39. L18. Granuloma formation in granulomatosis with polyangiitis. Holl-Ulrich K Presse Med; 2013 Apr; 42(4 Pt 2):555-8. PubMed ID: 23453208 [No Abstract] [Full Text] [Related]
40. c-ANCA as a marker of Wegener's disease. Clark HE Lancet; 1996 Jan; 347(8994):117; author reply 118. PubMed ID: 8538310 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]